The projected cost-of-living adjustment, or COLA, for Social Security beneficiaries in 2026 nudged slightly higher this week to 2.4% based on the latest inflation data. That’s up from last month’s estimates but still falls short of the 2.5% COLA retirees received in 2025.
It could also be the smallest benefit bump in five years.
Although inflation appears to be cooling — for now — experts warn that the 2026 COLA may not be enough to keep up with the real-world costs that many older Americans are facing, especially when it comes to essentials such as housing, groceries and medical care.
The annual COLA is based on the Consumer Price Index for Urban Wage Earners and Clerical Workers, or CPI-W. As of April, the CPI-W was just 2.1% higher than it was a year earlier, reflecting slower inflation overall.
That may sound like a relief — but it’s more complicated than you might think. Some of the biggest cost burdens for older adults, including food, housing and insurance, remain elevated. According to a note released Tuesday by independent Social Security and Medicare policy analyst Mary Johnson, “Consumer prices remain stubbornly higher for certain items, notably groceries [and] especially animal-based protein sources, such as meats and eggs.”
Both Johnson and The Senior Citizens League, a nonprofit advocacy group, are predicting a 2026 COLA adjustment of 2.4%.
New executive order could shift drug prices — or not
Because the CPI-W doesn’t provide a totally accurate picture of retiree spending — in particular, it leaves out the outsized healthcare costs older Americans pay — COLAs often fall short of meeting seniors’ financial needs. That said, one exception to the rising costs lately has been prescription medications.
According to data from the Bureau of Labor Statistics, drug prices have increased by only 2.3% over the past year. That’s a far slower pace than in previous years. The cost moderation is due largely to provisions in the Inflation Reduction Act, a 2022 law that requires drugmakers to pay rebates to Medicare if prices increase faster than inflation.
“That provision, which was widely supported by Medicare beneficiaries, could be restraining runaway drug prices,” Johnson noted.
Also in 2025, another cost-saving measure took effect: a new $2,000 cap on out-of-pocket costs for Medicare-covered prescription medications, giving older adults with chronic conditions some much-needed relief.
Adding complexity is a recent executive order from President Donald Trump that promotes “most-favored nation” pricing for prescription drugs. The order encourages linking U.S. drug prices to those paid in other countries, where government-negotiated rates are often significantly lower.
However, Johnson said that the order may not have much practical impact — at least, not yet. “An executive order… is not the same thing as a law change giving Medicare the authority to use these prices in negotiations with drug companies,” she said.
Instead, according to Johnson, the policy seems to promote direct-to-consumer imports of lower-priced medications from abroad, which may not directly affect Medicare-covered drug pricing.
“If that doesn’t muddy the waters enough, one has to wonder what effect tariffs would have on the final drug prices,” she added, referencing tariff policies that could drive costs back up.
The official COLA won’t be announced until October, when the Social Security Administration finalizes inflation data for July, August and September. Until then, analysts will continue to update their estimates as new inflation reports come in. As Johnson’s report puts it, her forecast “may still underestimate the final 2026 COLA,” especially as trade and health care policy changes loom in the background.
For now, Social Security beneficiaries should prepare for a modest boost in benefits come January — but keep a close eye on the economy and policymakers in Washington who could still shape the final outcome.
More from Money:
According to a report from The Money.com, our team conducts thorough research on all brands listed on our platform and may receive a fee from our partners. Our research and financial considerations may influence how these brands are displayed. It is important to note that not all brands are included in our research.
Based on the latest inflation data, the projected cost-of-living adjustment (COLA) for Social Security beneficiaries in 2026 has increased slightly to 2.4%. While this is higher than last month’s estimates, it falls short of the 2.5% COLA received in 2025. This could potentially be the smallest benefit increase in five years.
Experts warn that the 2026 COLA may not be enough to keep up with the real-world costs faced by many older Americans, especially when it comes to essentials such as housing, groceries, and medical care. The annual COLA is based on the Consumer Price Index for Urban Wage Earners and Clerical Workers (CPI-W). While inflation appears to be slowing down, certain expenses for older adults, such as food, housing, and insurance, remain high.
According to independent Social Security and Medicare policy analyst Mary Johnson, “Consumer prices remain stubbornly higher for certain items, notably groceries, especially animal-based protein sources, such as meats and eggs.” Both Johnson and The Senior Citizens League, a nonprofit advocacy group, predict a 2.4% COLA adjustment for 2026.
However, the CPI-W does not accurately reflect retiree spending, particularly when it comes to healthcare costs. This often results in COLAs falling short of meeting seniors’ financial needs. One exception to the rising costs has been prescription medications. The Bureau of Labor Statistics reports that drug prices have only increased by 2.3% over the past year, thanks to provisions in the Inflation Reduction Act and a new $2,000 cap on out-of-pocket costs for Medicare-covered prescription drugs.
Adding to the complexity is a recent executive order from President Donald Trump that promotes “most-favored nation” pricing for prescription drugs. While this may potentially lower drug prices, Johnson notes that it may not have a significant impact yet. ”
Source:Read More